Una Health is a technology company.
Una Health has raised $3.0M across 1 funding round.
Una Health has raised $3.0M in total across 1 funding round.
Una Health has raised $3.0M in total across 1 funding round.
Una Health's investors include Atlantic Food labs, FLORA Ventures, Shorea Ventures, Claire Novorol, Frank Westermann.
Una Health is a Berlin-based health tech startup developing AI-driven digital health solutions for metabolic conditions like Type 2 diabetes and obesity. It builds Una A.I., which uses digital twin technology to create personalized *Digital Metabolic Twins* and *Digital Behavioral Twins*, integrating biodata, lifestyle coaching, and AI for tailored recommendations that empower individuals and healthcare professionals to manage metabolic health proactively[1][6][7]. The platform serves patients with metabolic disorders, clinicians, and health systems, solving the global challenge of chronic conditions affecting hundreds of millions by enabling precision care, sustainable lifestyle changes, and early interventions through individualized insights on biology, behavior, and therapies like GLP-1 agonists[1]. Recent funding is accelerating R&D to bring this innovation to market faster, building on its expertise in human-centered health tech[1].
Una Health emerged from a mission to reverse metabolic dysfunction using precision nutrition, lifestyle management, mobile tech, biosensors, AI, and behavioral science[6][7]. While specific founders are not detailed in available sources, the company is rooted in Germany, specializing in digital solutions for Type 2 diabetes and metabolic health, combining biodata with coaching for habit-building[1]. A pivotal moment came with securing funding to advance Una A.I., doubling down on digital twin tech to model unique metabolic and behavioral profiles, marking a shift toward highly personalized, proactive care amid rising global metabolic challenges[1].
Una Health rides the AI-personalization wave in digital health, capitalizing on surging demand for precision medicine amid epidemics of diabetes, obesity, and cardiovascular disease affecting global populations[1]. Timing aligns with advances in AI, biosensors, and GLP-1 therapies, enabling digital twins to simulate individual responses for better outcomes than one-size-fits-all approaches[1]. Market forces like rising chronic disease prevalence and healthcare digitization favor its model, positioning it to influence ecosystems by empowering clinicians with data-driven insights and patients with accessible tools, potentially reducing system burdens through early, preventive interventions[1][7].
Next steps include rapid Una A.I. commercialization post-funding, expanding digital twin capabilities for broader metabolic therapies and integrations with wearables or health systems. Trends like AI-driven precision health and behavioral nudges will propel growth, evolving Una Health's influence from niche startup to key player in proactive metabolic care. This builds on its core strength in personalization, promising scalable impact as metabolic crises intensify.
Una Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $3.0M Seed | Atlantic Food labs, FLORA Ventures, Shorea Ventures, Claire Novorol, Frank Westermann |